Cargando…

Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia

INTRODUCTION: Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in childhood, related to prematurity, and the most common cause of pulmonary hypertension (PH) secondary to pulmonary disease in children. Moderate and severe BPD have a worse outcome and relate more frequently wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez-Fuente, Maria, Moreno, Laura, Lopez-Ortego, Paloma, Arruza, Luis, Avila-Alvarez, Alejandro, Muro, Marta, Gutierrez, Enrique, Zozaya, Carlos, Sanchez-Helguera, Gema, Elorza, Dolores, Martinez-Ramas, Andrea, Villar, Gema, Labrandero, Carlos, Martinez, Lucia, Casado, Teresa, Cuadrado, Irene, del Cerro, Maria Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402695/
https://www.ncbi.nlm.nih.gov/pubmed/30840669
http://dx.doi.org/10.1371/journal.pone.0213210
_version_ 1783400450345664512
author Alvarez-Fuente, Maria
Moreno, Laura
Lopez-Ortego, Paloma
Arruza, Luis
Avila-Alvarez, Alejandro
Muro, Marta
Gutierrez, Enrique
Zozaya, Carlos
Sanchez-Helguera, Gema
Elorza, Dolores
Martinez-Ramas, Andrea
Villar, Gema
Labrandero, Carlos
Martinez, Lucia
Casado, Teresa
Cuadrado, Irene
del Cerro, Maria Jesus
author_facet Alvarez-Fuente, Maria
Moreno, Laura
Lopez-Ortego, Paloma
Arruza, Luis
Avila-Alvarez, Alejandro
Muro, Marta
Gutierrez, Enrique
Zozaya, Carlos
Sanchez-Helguera, Gema
Elorza, Dolores
Martinez-Ramas, Andrea
Villar, Gema
Labrandero, Carlos
Martinez, Lucia
Casado, Teresa
Cuadrado, Irene
del Cerro, Maria Jesus
author_sort Alvarez-Fuente, Maria
collection PubMed
description INTRODUCTION: Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in childhood, related to prematurity, and the most common cause of pulmonary hypertension (PH) secondary to pulmonary disease in children. Moderate and severe BPD have a worse outcome and relate more frequently with PH. The prediction of moderate or severe BPD development in extremely premature newborns is vital to implement preventive strategies. Starting with the hypothesis that molecular biomarkers were better than clinical and echocardiographic factors, this study aims to explore the ability of clinical, echocardiographic and analytical variables to predict moderate or severe BPD in a cohort of extremely preterm infants. PATIENTS AND METHODS: We designed a prospective longitudinal study, in which we followed a cohort of preterm newborns (gestational age <28 weeks and weight ≤ 1250 grams). In these newborns we recorded weekly clinical and echocardiographic variables as well as blood and tracheal aspirate samples, to analyze molecular biomarkers (IL-6, IL-1, IP10, uric acid, HGF, endothelin-1, VEGF, CCL5). Variables and samples were collected since birth up to week 36 (postmenstrual age), time-point at which the diagnosis of BPD is established. RESULTS: We included 50 patients with a median gestational age of 26 weeks (IQR 25–27) and weight of 871 g (SD 161,0) (range 590-1200g). Three patients were excluded due to an early death. Thirty-five patients (74.5%) developed BPD (mild n = 14, moderate n = 15, severe n = 6). We performed a logistic regression in order to identify risk factors for moderate or severe BPD. We compared two predictive models, one with two variables (mechanical ventilation and inter-ventricular septum flattening), and another-one with an additional molecular biomarker (ET-1). CONCLUSIONS: The combination of clinical and echocardiographic variables is a valuable tool for determining the risk of BPD. We find the two variable model (mechanical ventilation and echocardiographic signs of PH) more practical for clinical and research purposes. Future research on BPD prediction should be oriented to explore the potential role of ET-1.
format Online
Article
Text
id pubmed-6402695
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-64026952019-03-17 Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia Alvarez-Fuente, Maria Moreno, Laura Lopez-Ortego, Paloma Arruza, Luis Avila-Alvarez, Alejandro Muro, Marta Gutierrez, Enrique Zozaya, Carlos Sanchez-Helguera, Gema Elorza, Dolores Martinez-Ramas, Andrea Villar, Gema Labrandero, Carlos Martinez, Lucia Casado, Teresa Cuadrado, Irene del Cerro, Maria Jesus PLoS One Research Article INTRODUCTION: Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in childhood, related to prematurity, and the most common cause of pulmonary hypertension (PH) secondary to pulmonary disease in children. Moderate and severe BPD have a worse outcome and relate more frequently with PH. The prediction of moderate or severe BPD development in extremely premature newborns is vital to implement preventive strategies. Starting with the hypothesis that molecular biomarkers were better than clinical and echocardiographic factors, this study aims to explore the ability of clinical, echocardiographic and analytical variables to predict moderate or severe BPD in a cohort of extremely preterm infants. PATIENTS AND METHODS: We designed a prospective longitudinal study, in which we followed a cohort of preterm newborns (gestational age <28 weeks and weight ≤ 1250 grams). In these newborns we recorded weekly clinical and echocardiographic variables as well as blood and tracheal aspirate samples, to analyze molecular biomarkers (IL-6, IL-1, IP10, uric acid, HGF, endothelin-1, VEGF, CCL5). Variables and samples were collected since birth up to week 36 (postmenstrual age), time-point at which the diagnosis of BPD is established. RESULTS: We included 50 patients with a median gestational age of 26 weeks (IQR 25–27) and weight of 871 g (SD 161,0) (range 590-1200g). Three patients were excluded due to an early death. Thirty-five patients (74.5%) developed BPD (mild n = 14, moderate n = 15, severe n = 6). We performed a logistic regression in order to identify risk factors for moderate or severe BPD. We compared two predictive models, one with two variables (mechanical ventilation and inter-ventricular septum flattening), and another-one with an additional molecular biomarker (ET-1). CONCLUSIONS: The combination of clinical and echocardiographic variables is a valuable tool for determining the risk of BPD. We find the two variable model (mechanical ventilation and echocardiographic signs of PH) more practical for clinical and research purposes. Future research on BPD prediction should be oriented to explore the potential role of ET-1. Public Library of Science 2019-03-06 /pmc/articles/PMC6402695/ /pubmed/30840669 http://dx.doi.org/10.1371/journal.pone.0213210 Text en © 2019 Alvarez-Fuente et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Alvarez-Fuente, Maria
Moreno, Laura
Lopez-Ortego, Paloma
Arruza, Luis
Avila-Alvarez, Alejandro
Muro, Marta
Gutierrez, Enrique
Zozaya, Carlos
Sanchez-Helguera, Gema
Elorza, Dolores
Martinez-Ramas, Andrea
Villar, Gema
Labrandero, Carlos
Martinez, Lucia
Casado, Teresa
Cuadrado, Irene
del Cerro, Maria Jesus
Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
title Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
title_full Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
title_fullStr Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
title_full_unstemmed Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
title_short Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
title_sort exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402695/
https://www.ncbi.nlm.nih.gov/pubmed/30840669
http://dx.doi.org/10.1371/journal.pone.0213210
work_keys_str_mv AT alvarezfuentemaria exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT morenolaura exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT lopezortegopaloma exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT arruzaluis exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT avilaalvarezalejandro exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT muromarta exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT gutierrezenrique exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT zozayacarlos exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT sanchezhelgueragema exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT elorzadolores exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT martinezramasandrea exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT villargema exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT labranderocarlos exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT martinezlucia exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT casadoteresa exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT cuadradoirene exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia
AT delcerromariajesus exploringclinicalechocardiographicandmolecularbiomarkerstopredictbronchopulmonarydysplasia